Your browser doesn't support javascript.
loading
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.
Holderfield, Matthew; Deuker, Marian M; McCormick, Frank; McMahon, Martin.
Afiliação
  • Holderfield M; 1] Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, California 94158, USA. [2].
  • Deuker MM; 1] Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, California 94158, USA. [2].
  • McCormick F; Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, California 94158, USA.
  • McMahon M; Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, California 94158, USA.
Nat Rev Cancer ; 14(7): 455-67, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24957944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article